Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Gross Profit (2016 - 2025)

Apyx Medical (APYX) has disclosed Gross Profit for 15 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 33.86% year-over-year to $12.0 million, compared with a TTM value of $33.0 million through Dec 2025, up 12.55%, and an annual FY2025 reading of $33.0 million, up 12.55% over the prior year.
  • Gross Profit was $12.0 million for Q4 2025 at Apyx Medical, up from $8.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $12.2 million in Q4 2021 and bottomed at $5.7 million in Q1 2025.
  • Average Gross Profit over 5 years is $7.9 million, with a median of $7.8 million recorded in 2023.
  • The sharpest move saw Gross Profit skyrocketed 259.79% in 2021, then crashed 32.18% in 2022.
  • Year by year, Gross Profit stood at $12.2 million in 2021, then tumbled by 32.18% to $8.2 million in 2022, then grew by 8.35% to $8.9 million in 2023, then grew by 0.39% to $9.0 million in 2024, then skyrocketed by 33.86% to $12.0 million in 2025.
  • Business Quant data shows Gross Profit for APYX at $12.0 million in Q4 2025, $8.3 million in Q3 2025, and $7.1 million in Q2 2025.